MORGAN STANLEY - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 52 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$145,945
-24.6%
167,772
-2.9%
0.00%
Q2 2023$193,536
+260.3%
172,800
+234.6%
0.00%
Q1 2023$53,708
+12.4%
51,643
+21.1%
0.00%
Q4 2022$47,763
-64.1%
42,646
-63.8%
0.00%
Q3 2022$133,000
-85.0%
117,677
-80.4%
0.00%
Q2 2022$885,000
-66.2%
601,732
-47.3%
0.00%
Q1 2022$2,615,000
-40.8%
1,141,840
-28.9%
0.00%
-100.0%
Q4 2021$4,417,000
-8.7%
1,606,405
+99.2%
0.00%0.0%
Q3 2021$4,839,000
+247.6%
806,555
+182.1%
0.00%
Q2 2021$1,392,000
+57.1%
285,861
-20.3%
0.00%
Q1 2021$886,000
+7283.3%
358,647
+8275.7%
0.00%
Q4 2020$12,000
-81.0%
4,282
-87.2%
0.00%
Q2 2020$63,000
-85.7%
33,561
-87.0%
0.00%
Q1 2020$440,000
+43900.0%
259,115
+14013.0%
0.00%
Q3 2019$1,0001,836
+6231.0%
0.00%
Q2 2019$0
-100.0%
29
-99.3%
0.00%
Q1 2019$6,000
-90.6%
4,136
-93.1%
0.00%
Q4 2018$64,000
-93.6%
59,837
-63.4%
0.00%
Q3 2018$1,006,000
+29.6%
163,548
+125.5%
0.00%
Q2 2018$776,000
+33.3%
72,542
+33.6%
0.00%
Q1 2018$582,000
+59.9%
54,298
+4.3%
0.00%
Q4 2017$364,000
-10.8%
52,060
+11.7%
0.00%
Q3 2017$408,000
+56.3%
46,623
+62.8%
0.00%
Q2 2017$261,000
-29.8%
28,639
-38.9%
0.00%
Q1 2017$372,000
-28.5%
46,878
-19.2%
0.00%
Q4 2016$520,000
+4233.3%
58,002
+3415.3%
0.00%
Q2 2016$12,0001,6500.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q1 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,467,500$14,805,0007.67%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$7,898,0002.79%
AJU IB Investment Co., Ltd. 293,555$1,761,0001.14%
RTW INVESTMENTS, LP 4,206,765$25,241,0000.38%
EAM Investors, LLC 247,561$1,485,0000.25%
Carmignac Gestion 2,475,652$14,854,0000.18%
Curi Wealth Management, LLC 25,000$150,0000.07%
CAXTON ASSOCIATES LP 66,569$399,0000.04%
Newman Dignan & Sheerar, Inc. 21,523$129,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,900,0000.04%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders